2022 annual financial data
Marker Therapeutics 2022 Net income
Direct answer
Net income was -29,930,694 USD.
Operating income was -19,791,004 USD and net income was -29,930,694 USD.
Operating cash flow was -26,972,153 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,513,544 USD
- Operating income
- -19,791,004 USD
- Net income
- -29,930,694 USD
- Operating cash flow
- -26,972,153 USD